Abstract
Purpose
The purpose of the study was to evaluate the physiological accumulation of 18F-FDG in the muscles in relation to the side of intravenous administration.
Materials and methods
We retrospectively investigated 3,118 18F-FDG-PET/CT examinations. We evaluated the physiological accumulation of FDG in the muscles of the shoulder and arm relative to its dependence on the side of intravenous administration.
Results
Six hundred six of the 3,118 examinations (19.4%) showed physiological accumulation of FDG in the teres minor muscle. Accumulation was seen on the side of administration in 486 examinations (80.2%), contralateral to the side of administration in 56 examinations (9.2%), and bilaterally in 64 examinations (10.6%). Five hundred seventy-seven of the 3,118 examinations (18.5%) showed accumulation of FDG in the muscles between the radioulna near the elbow. Accumulation was observed on the side of administration in 432 examinations (74.9%), contralateral to the side of the administration in 71 examinations (12.3%), and bilaterally in 74 examinations (12.8%).
Conclusion
The present study finds that not only accumulation in the teres minor muscles but also accumulation in the muscles between the radioulna near the elbow occurs significantly more frequently on the side of intravenous administration compared to the contralateral side.
Similar content being viewed by others
References
Engel H, Steinert H, Buck A, Berthold T, Huch Böni RA, von Schulthess GK. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med. 1996;37:441–6.
Jackson RS, Schlarman TC, Hubble WL, Osman MM. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J Nucl Med Technol. 2006;34:29–33.
Tashiro M, Fujimoto T, Itoh M, Kubota K, Fujiwara T, Miyake M, et al. 18F-FDG PET imaging of muscle activity in runners. J Nucl Med. 1999;40:70–6.
Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308–14.
Kostakoglu L, Wong JC, Barrington SF, Cronin BF, Dynes AM, Maisey MN. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. J Nucl Med. 1996;37:1771–3.
Kelley DE, Williams KV, Price JC. Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET. Am J Physiol. 1999;277:E361–9.
Nuutila P, Knuuti MJ, Mäki M, Laine H, Ruotsalainen U, Teräs M, et al. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes. 1995;44:31–6.
Schwartz P Jr, Pinaquy JB. Unilateral forearm muscle 18F-FDG uptake after using a smartphone. Clin Nucl Med. 2015;40:e532–3.
Tateyama M, Fujihara K, Misu T, Arai A, Kaneta T, Aoki M. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation. BMJ Open. 2015;5:e006763.
Tanaka S, Ikeda K, Uchiyama K, Iwamoto T, Sanayama Y, Okubo A, et al. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis. Rheumatology (Oxford). 2013;52:1271–8.
Han EJ, Jang YS, Lee IS, Lee JM, Kang S, Kim HS. Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient. J Korean Med Sci. 2013;28:1399–402.
Marie I, Lahaxe L, Vera P, Edet-Samson A. Follow-up of muscular sarcoidosis using fluorodeoxyglucose positron emission tomography. QJM. 2010;103:1000–2.
Nieweg OE, Pruim J, van Ginkel RJ, Hoekstra HJ, Paans AM, Molenaar WM, et al. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med. 1996;37:257–61.
Shin DS, Shon OJ, Han DS, Choi JH, Chun KA, Cho IH. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors. Ann Nucl Med. 2008;22:603–9.
Nakatani K, Nakamoto Y, Togashi K. Unilateral physiological FDG uptake in teres minor muscle seems well associated with IV tracer injection procedures. Clin Nucl Med. 2015;40:62–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose with respect to this work.
Ethical statement
This study was approved without the need for individual informed consent by our institutional ethics committee and is in accordance with the 1964 Declaration of Helsinki and its later amendments.
About this article
Cite this article
Otomi, Y., Shinya, T., Uyama, N. et al. The physiological accumulation of FDG in the muscles in relation to the side of intravenous administration. Jpn J Radiol 35, 53–60 (2017). https://doi.org/10.1007/s11604-016-0597-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-016-0597-4